Market closed
Eterna Therapeutics Inc./$ERNA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Eterna Therapeutics Inc.
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.
Ticker
$ERNA
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
6
Website
ERNA Metrics
BasicAdvanced
$11M
-
-$3.26
7.33
-
Price and volume
Market cap
$11M
Beta
7.33
52-week high
$0.30
52-week low
$0.15
Average daily volume
190K
Financial strength
Current ratio
0.801
Quick ratio
0.737
Long term debt to equity
28.042
Total debt to equity
40.212
Interest coverage (TTM)
-2.55%
Management effectiveness
Return on assets (TTM)
-39.64%
Return on equity (TTM)
-2,264.31%
Valuation
Price to revenue (TTM)
4.891
Price to book
6.31
Price to tangible book (TTM)
-31.16
Price to free cash flow (TTM)
-0.176
Growth
Revenue change (TTM)
755.88%
Earnings per share change (TTM)
-19.99%
3-year earnings per share growth (CAGR)
-61.36%
ERNA News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Eterna Therapeutics Inc. stock?
Eterna Therapeutics Inc. (ERNA) has a market cap of $11M as of April 16, 2025.
What is the P/E ratio for Eterna Therapeutics Inc. stock?
The price to earnings (P/E) ratio for Eterna Therapeutics Inc. (ERNA) stock is 0 as of April 16, 2025.
Does Eterna Therapeutics Inc. stock pay dividends?
No, Eterna Therapeutics Inc. (ERNA) stock does not pay dividends to its shareholders as of April 16, 2025.
When is the next Eterna Therapeutics Inc. dividend payment date?
Eterna Therapeutics Inc. (ERNA) stock does not pay dividends to its shareholders.
What is the beta indicator for Eterna Therapeutics Inc.?
Eterna Therapeutics Inc. (ERNA) has a beta rating of 7.33. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.